Proportion of clinically significant prostate cancer diagnosed by systematic template biopsy after negative pre-biopsy multiparametric magnetic resonance imaging and predictive value of prostate-specific antigen density
DOI:
https://doi.org/10.5489/cuaj.7455Keywords:
clinically significant prostate cancer, systematic template biopsy, negative pre-biopsy multiparametric MRI, PSA densityAbstract
Biopsy deferral in men with a negative prostate multiparametric magnetic resonance imaging (mpMRI) is gaining popularity in clinical practice, as mpMRI becomes integrated into prostate cancer (PCa) diagnostic pathways.1 However, clinically significant (cs)PCa may be diagnosed at subsequent template biopsy in men with negative pre-biopsy mpMRI.2 This study evaluated the proportion of men with csPCa diagnosis at template biopsy following a negative mpMRI and evaluated prostate-specific antigen (PSA) density as a predictor of future positive template biopsy.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:
- Post the Article on any Web site
- Translate or authorize a translation of the Article
- Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
- Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.
The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.
You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.
The CUA also requires you to warrant the following:
- That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
- That all individuals who have made a substantive contribution to the article are acknowledged;
- That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
- That the Article does not libel or violate the privacy rights of any third party.